Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PD7X
|
|||
| Former ID |
DNC011691
|
|||
| Drug Name |
2'-Nitro-biphenyl-4-carboxylic acid hydroxyamide
|
|||
| Synonyms |
CHEMBL177084; BDBM50015162; ZINC28086552; 2''-Nitro-biphenyl-4-carboxylic acid hydroxyamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H10N2O4
|
|||
| Canonical SMILES |
C1=CC=C(C(=C1)C2=CC=C(C=C2)C(=O)NO)[N+](=O)[O-]
|
|||
| InChI |
1S/C13H10N2O4/c16-13(14-17)10-7-5-9(6-8-10)11-3-1-2-4-12(11)15(18)19/h1-8,17H,(H,14,16)
|
|||
| InChIKey |
MDYLSZYFKUGXHL-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Arachidonate 5-lipoxygenase (5-LOX) | Target Info | Inhibitor | [1] |
| BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
| Resolvin D biosynthesis | ||||
| Leukotriene biosynthesis | ||||
| Lipoxin biosynthesis | ||||
| Aspirin triggered resolvin D biosynthesis | ||||
| Aspirin triggered resolvin E biosynthesis | ||||
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Serotonergic synapse | ||||
| Ovarian steroidogenesis | ||||
| Toxoplasmosis | ||||
| NetPath Pathway | IL4 Signaling Pathway | |||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Vitamin D Receptor Pathway | |||
| Arachidonic acid metabolism | ||||
| Eicosanoid Synthesis | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships. J Med Chem. 1990 Mar;33(3):992-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.